Neil Almstead
Dr. Almstead has served as our Chief Technical Operations Officer since December 2018. Dr. Almstead has been employed with PTC since 2000. He served as our Executive Vice President, Research, Pharmaceutical Operations and Technology from January 2015 to December 2018, Senior Vice President, Research and CMC from July 2008 to December 2014 and Senior Vice President, Chemistry and CMC from January 2007 to June 2008. Prior to joining PTC, Dr. Almstead served as Project Manager at Procter & Gamble Company, a publicly traded consumer products company. Dr. Almstead has co-authored more than 75 publications and patents pertaining to the design and synthesis of lead candidate compounds for genetic disorders, oncology and inflammatory diseases. Dr. Almstead received a B.S. from Clarkson University and a Ph.D. in Organic Chemistry from the University of Illinois at Urbana-Champaign.; Chief Technical Operations Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Ptc Therapeutics, Inc. (PTCT) | Chief Technical Operations Officer | $468,000 | $2,518,769 |
| 2018 | Ptc Therapeutics, Inc. (PTCT) | Chief Technical Operations Officer | $434,969 | $1,609,441 |
| 2017 | Ptc Therapeutics, Inc. (PTCT) | Chief Technical Operations Officer | $434,969 | $951,918 |
Earnings-call appearances
No earnings-call appearances recorded yet.